Asia Pacific Molecular Diagnostics Market By Product & Services (Reagents & Kits, Instruments, Software & Services), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Hybridization, DNA Sequencing & Next-Generation Sequencing, Microarray), Application (Infectious Diseases, Oncology, Blood Screening, Genetic Tests, Microbiology), End User (Hospital & Academic Laboratories, Reference Laboratories)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia-Pacific Molecular Diagnostics Market, by Product & Services
1.4.2 Asia-Pacific Molecular Diagnostics Market, by Technology
1.4.3 Asia-Pacific Molecular Diagnostics Market, by Application
1.4.4 Asia-Pacific Molecular Diagnostics Market, by End User
1.4.5 Asia-Pacific Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Asia-Pacific Molecular Diagnostics Market
4.1 Asia-Pacific Molecular Diagnostics Market by Product & Services
4.1.1 Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Asia-Pacific Molecular Diagnostics Instruments Market by Country
4.1.3 Asia-Pacific Molecular Diagnostics Software & Services Market by Country
Chapter 5. Asia-Pacific Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Asia-Pacific Hybridization Molecular Diagnostics Market by Country
5.1.4 Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Asia-Pacific Microarray Molecular Diagnostics Market by Country
5.1.6 Asia-Pacific Other Technologies Market by Country
Chapter 6. Asia-Pacific Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Asia-Pacific Oncology Molecular Diagnostics Market by Country
6.1.4 Asia-Pacific Oncology Molecular Diagnostics Market by Type
6.1.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Asia-Pacific Other Cancers Molecular Diagnostics Market by Country
6.1.5 Asia-Pacific Blood Screening Molecular Diagnostics Market by Country
6.1.6 Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Asia-Pacific Microbiology Molecular Diagnostics Market by Country
6.1.8 Asia-Pacific Other Applications Market by Country
Chapter 7. Asia-Pacific Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Asia-Pacific Molecular Diagnostics Market for Other End Users by Country
Chapter 8. Asia-Pacific Molecular Diagnostics Market by Country
8.1 Introduction
8.2 China Molecular Diagnostics Market
8.2.1 China Molecular Diagnostics Market by Product & Services
8.2.2 China Molecular Diagnostics Market by Technology
8.2.3 China Molecular Diagnostics Market by Application
8.2.3.1 China Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 China Oncology Molecular Diagnostics Market by Type
8.2.4 China Molecular Diagnostics Market by End User
8.3 Japan Molecular Diagnostics Market
8.3.1 Japan Molecular Diagnostics Market by Product & Services
8.3.2 Japan Molecular Diagnostics Market by Technology
8.3.3 Japan Molecular Diagnostics Market by Application
8.3.3.1 Japan Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Japan Oncology Molecular Diagnostics Market by Type
8.3.4 Japan Molecular Diagnostics Market by End User
8.4 India Molecular Diagnostics Market
8.4.1 India Molecular Diagnostics Market by Product & Services
8.4.2 India Molecular Diagnostics Market by Technology
8.4.3 India Molecular Diagnostics Market by Application
8.4.3.1 India Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 India Oncology Molecular Diagnostics Market by Type
8.4.4 India Molecular Diagnostics Market by End User
8.5 South Korea Molecular Diagnostics Market
8.5.1 South Korea Molecular Diagnostics Market by Product & Services
8.5.2 South Korea Molecular Diagnostics Market by Technology
8.5.3 South Korea Molecular Diagnostics Market by Application
8.5.3.1 South Korea Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 South Korea Oncology Molecular Diagnostics Market by Type
8.5.4 South Korea Molecular Diagnostics Market by End User
8.6 Australia Molecular Diagnostics Market
8.6.1 Australia Molecular Diagnostics Market by Product & Services
8.6.2 Australia Molecular Diagnostics Market by Technology
8.6.3 Australia Molecular Diagnostics Market by Application
8.6.3.1 Australia Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Australia Oncology Molecular Diagnostics Market by Type
8.6.4 Australia Molecular Diagnostics Market by End User
8.7 Singapore Molecular Diagnostics Market
8.7.1 Singapore Molecular Diagnostics Market by Product & Services
8.7.2 Singapore Molecular Diagnostics Market by Technology
8.7.3 Singapore Molecular Diagnostics Market by Application
8.7.3.1 Singapore Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Singapore Oncology Molecular Diagnostics Market by Type
8.7.4 Singapore Molecular Diagnostics Market by End User
8.8 Rest of Asia-Pacific Molecular Diagnostics Market
8.8.1 Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Asia-Pacific Molecular Diagnostics Market by Technology
8.8.3 Rest of Asia-Pacific Molecular Diagnostics Market by Application
8.8.3.1 Rest of Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Asia-Pacific Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Asia-Pacific Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense